|Bid||43.16 x 1000|
|Ask||44.79 x 900|
|Day's range||42.50 - 44.32|
|52-week range||35.33 - 63.46|
|Beta (5Y monthly)||1.22|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||1.80 (4.09%)|
|Ex-dividend date||31 Mar 2023|
|1y target est||N/A|
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
Welltower and Ventas got hammered during the pandemic because of their senior housing assets. That's changing in a big way.
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The SHOP same-store NOI improves on strong pricing power and occupancy growth. It issues 2023 outlook.